塑料化合物和肝脏疾病:双 A 是否是唯一的罪祸首
Sonal Sangwan1, Rajasri Bhattacharyya1, Dibyajyoti Banerjee1
1Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
概括
塑料污染物,包括双甲 (BPA),与肝病有关,特别是非酒精性脂肪肝病 (NAFLD). 需要采取紧急行动来解决塑料污染问题.
科学领域:
- 环境科学 环境科学
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
背景情况:
- 塑料污染是一个普遍存在的全球环境问题.
- 双A (BPA) 和它的类似物是造成这种污染的重要因素.
- 新兴研究强调了塑料衍生品与肝脏病理,包括胆固醇症之间的联系.
研究的目的:
- 审查将塑料污染物暴露与肝脏疾病联系在一起的分子机制.
- 强调塑料,特别是BPA在非酒精性脂肪肝疾病 (NAFLD) 病原体中的作用.
- 强调应对塑料污染作为重大环境健康风险的紧迫性.
主要方法:
- 关于塑料污染和肝脏疾病的科学研究的文献综述.
- 分析涉及BPA和其他塑料衍生物毒性的分子途径.
- 综合证据,将环境污染物与NAFLD进展联系起来.
主要成果:
- 双甲 (BPA) 涉及非酒精性脂肪肝疾病 (NAFLD) 发展和进展的所有阶段.
- 乙正在成为慢性肝病的主要原因,超过了乙型肝炎病毒.
- 除了BPA外,其他双相似物,微塑料和纳米塑料都可能对肝脏健康构成潜在的风险.
结论:
- 塑料污染物是全球肝脏健康的重大和日益增长的威胁.
- 了解塑料造成的分子破坏对于减轻NAFLD至关重要.
- 需要采取全面的战略来减少塑料污染及其对健康的影响.
相关概念视频
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Diseases of the Liver and Gallbladder
538
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
538
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
39
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
39
Hepatic Drug Excretion: Influencing Factors
130
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
130
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
244
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
244
Factors Affecting Drug Biotransformation: Biological
149
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
149


